233 related articles for article (PubMed ID: 28329280)
1. Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
Shun-Shin MJ; Zheng SL; Cole GD; Howard JP; Whinnett ZI; Francis DP
Eur Heart J; 2017 Jun; 38(22):1738-1746. PubMed ID: 28329280
[TBL] [Abstract][Full Text] [Related]
2. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
[TBL] [Abstract][Full Text] [Related]
4. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
Peck KY; Lim YZ; Hopper I; Krum H
Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice.
Masoudi FA; Go AS; Magid DJ; Cassidy-Bushrow AE; Doris JM; Fiocchi F; Garcia-Montilla R; Glenn KA; Goldberg RJ; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Jackson N; Kadish A; Lauer M; Miller AW; Multerer D; Peterson PN; Reifler LM; Reynolds K; Saczynski JS; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Greenlee RT
Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):e78-85. PubMed ID: 23170006
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis.
Theuns DA; Smith T; Hunink MG; Bardy GH; Jordaens L
Europace; 2010 Nov; 12(11):1564-70. PubMed ID: 20974768
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
9. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.
Katritsis DG; Siontis KC; Bigger JT; Kadish AH; Steinman R; Zareba W; Siontis GC; Bardy GH; Ioannidis JP
Heart Rhythm; 2013 Feb; 10(2):200-6. PubMed ID: 23107652
[TBL] [Abstract][Full Text] [Related]
10. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.
Beggs SAS; Jhund PS; Jackson CE; McMurray JJV; Gardner RS
Heart; 2018 Jan; 104(2):144-150. PubMed ID: 28986406
[TBL] [Abstract][Full Text] [Related]
11. Effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure and concurrent coronary atherosclerosis.
Byrne C; Ahlehoff O; Elming MB; Pedersen F; Pehrson S; Nielsen JC; Eiskjaer H; Videbaek L; Svendsen JH; Haarbo J; Thøgersen AM; Køber L; Thune JJ
ESC Heart Fail; 2022 Apr; 9(2):1287-1293. PubMed ID: 35106935
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter/defibrillator interventions in primary prevention: do current implantation criteria really predict ICD interventions?
Cools T; Rossenbacker T; Floré V; Nuyens D; Heidbochel H; Willems R
Acta Cardiol; 2011 Apr; 66(2):145-51. PubMed ID: 21591571
[TBL] [Abstract][Full Text] [Related]
14. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Stavrakis S; Asad Z; Reynolds D
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
[TBL] [Abstract][Full Text] [Related]
15. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
Kreuz J; Horlbeck F; Schrickel J; Linhart M; Fimmers R; Mellert F; Nickenig G; Schwab JO
Clin Cardiol; 2012 Sep; 35(9):575-9. PubMed ID: 22707222
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Akel T; Lafferty J
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.
Barakat AF; Saad M; Elgendy AY; Mentias A; Abuzaid A; Mahmoud AN; Elgendy IY
BMJ Open; 2017 Jun; 7(6):e016352. PubMed ID: 28637742
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.
Wolff G; Lin Y; Karathanos A; Brockmeyer M; Wolters S; Nowak B; Fürnkranz A; Makimoto H; Kelm M; Schulze V
Clin Res Cardiol; 2017 Jul; 106(7):501-513. PubMed ID: 28213711
[TBL] [Abstract][Full Text] [Related]
19. An implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis.
Wasiak M; Tajstra M; Kosior D; Gąsior M
Cardiol J; 2023; 30(1):117-124. PubMed ID: 33843044
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
